HIGHLIGHTS
- who: Filip Vlavcheski and colleagues from the Department of Health Sciences, Brock University, StCatharines, ON L S , Canada have published the paper: Effects of Berberine against Pancreatitis and Pancreatic Cancer, in the Journal: Molecules 2022, 27, x FOR PEER REVIEW of /2022/
- what: Ultimately, this study shows that BBR administered orally reaches high enough concentrations in_vivo to slow tumour growth and that BBR acts synergistically with cholesterol-lowering medications such as lovastatin.
- future: Despite 10 years of intensive research bioprinted tissues have not reached adequate morphological and functional organicity to make them an . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.